Limited but Growing Use of Medications for Alcohol Use Disorder by Gastroenterologists: A Medicare Analysis, 2016-2024. [PDF]
Huskamp HA +5 more
europepmc +1 more source
Pharmacists expand access to contingency management in patients with substance use disorders. [PDF]
Salsman M +5 more
europepmc +1 more source
Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01. [PDF]
Lixi F +7 more
europepmc +1 more source
Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects? [PDF]
Parkerson JA +3 more
europepmc +1 more source
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]
Appa A +8 more
europepmc +1 more source
Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials. [PDF]
McManus KR, Ray LA.
europepmc +1 more source
Pharmacotherapy for Alcohol Use Disorder: A Brief Review of Available Options and Their Integration With Lifestyle Medicine Approaches. [PDF]
Caples D, Srivastava S.
europepmc +1 more source
Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids. [PDF]
Juárez-Núñez C +6 more
europepmc +1 more source
Case report: the challenges of psychogenic polydipsia. [PDF]
Raha A, Mordekar A.
europepmc +1 more source
Extemporaneous Preparation and Effectiveness of Low-Dose Naltrexone for the Treatment of Uremic Pruritus: A Literature Review and Case Report. [PDF]
Rungkitwattanakul D +7 more
europepmc +1 more source

